Influencing and shaping our sector BIA update: January - April 2024

BIA response to NICE consultation on integrated topic prioritisation and strategic principles

BIA response to NICE consultation on including technology appraisal recommendations in guideline topic areas

BIA Webinar: Life sciences and politics in Spring 2024

BIA Webinar - China SIG 2024 outlook: current biopharma market conditions and opportunities

Join us for this special update webinar, hosted by BIA and chaired by DBT China

Deep Biotech: Disruptive innovation for global sustainability

The BIA has coined the term ‘Deep Biotech’ to capture companies working in this biotech space. This report aims to shine a light on some of the innovative companies using engineering biology to positively disrupt the environmentally damaging industries that modern society relies on.

UK biotech financing 2023

Despite the global economic downturn, UK life sciences companies secured £1.25 billion in venture financing, constituting 11% of the total venture capital investment in UK companies this year.

BIA's submission to HMT's Spring Budget 2024

The BIA has submitted a representation to HM Treasury ahead of the Spring Budget scheduled for March.

Influencing and shaping our sector BIA update: October 2023 - January 2024

An overview of the BIA's influencing work on behalf of the innovative life science and biotech sector between October 2023 and January 2024.

BIA submission to DBT’s call for evidence on smarter regulation

The BIA has responded to the Department for Business and Trade’s call for evidence on smarter regulation and the regulatory landscape